Nevertheless, our results suggest that the therapeutic effect observed in animal models of lung fibrosis is unlikely to originate from inhibition of DPP4 on tissue-resident THY1+ fibroblasts. This evidence concerns the gene DPP4 and pulmonary fibrosis.